• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

VistaGen Therapeutics Inc

+ Add to Watchlist


8.5000 USD 0.2500 2.86%

As of 17:20:18 ET on 12/17/2014.

Snapshot for VistaGen Therapeutics Inc (VSTA)

Open: 8.5000 Day's Range: 8.5000 - 8.5000 Volume: 200
Previous Close: 8.7500 52wk Range: 5.5075 - 15.0000 1-Yr Rtn: +41.67%

Stock Chart for VSTA

No chart data available.
  • VSTA:US 8.5000
  • 1D
  • 1M
  • 1Y
Interactive VSTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VSTA

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -5.5800
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 11.00
Shares Outstanding (M) 1.29
30 Day Average Volume 48
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VSTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VSTA

VistaGen Therapeutics, Inc. is a biotechnology company. The Company combines stem cell technology with chemistry to create new chemical variants of drug candidates that have been discontinued during preclinical development due to heart or liver safety concerns. VistaGen also researches repairing, replacing or restoring damaged tissues or organs.

Shawn K SinghChief Executive OfficerH Ralph SnodgrassPres/Chief Scientific Officer
Jerrold Duane DotsonVP/CFO/Secretary
More Company Profile & Key Executives for VSTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil